| GD | glomerular disease |
| GDAM | glomerular disease associated with malignancy |
| PLA2R | phospholipase A2 receptor |
| ANCA | antineutrophil cytoplasmic autoantibodies |
| MPO | myeloperoxidase |
| PR3 | proteinase 3 |
| ESKD | end stage kidney disease |
| ANA | anti-nuclear autoantibodies |
| PI-GN | pauci-immune glomerulonephritis |
| RPGN | rapidly progressive glomerulonephritis |
| GFR | glomerular filtration rate |
| MPGN | membranoproliferative glomerulonephritis |
| MN | membranous nephropathy |
| IgAN | IgA nephropathy |
| MCD | minimal change disease |
| GN | glomerulonephritis |
| FSGS | focal segmental glomerulosclerosis |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.